Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma

Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma

Abstract Background The combination of rituximab and chemotherapy is a first-line treatment for patients with B-cell non-Hodgkin lymphoma. Lenalidomide is an immunomodulatory drug that has shown promising properties and activity in a variety of hematological malignancies. This study evaluated the ef...

Full description

Bibliographic Details
Main Authors: Yang Liu, Yanju Li, Chike Zhang, Xu Yang, Bo Yang, Jinyang Cheng, Juan Chen, Xiaoshuang Yuan, Ya Li, Ying Chen, Fengqi Zhang, Dongxin Tang, Zhixu He, Feiqing Wang
Format: Article
Language:English
Published: Springer 2024-04-01
Series:Discover Oncology
Subjects:
Mantle cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
Diffuse large B cell lymphoma
Lenalidomide
Online Access:https://doi.org/10.1007/s12672-024-00965-7

Internet

https://doi.org/10.1007/s12672-024-00965-7

Similar Items